𝔖 Bobbio Scriptorium
✦   LIBER   ✦

658 - Phase II dose-finding trial of CAELYX™ (Stealth® liposomal doxorubicin HCL) in the treatment of advanced breast cancer

✍ Scribed by M. Ranson; K. O’Byrne; J. Carmichael; D. Smith; S. Stewart; A. Howell


Book ID
117664905
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
266 KB
Volume
33
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Caelyx (stealth liposomal doxorubicin) i
✍ M.R. Ranson; S. Cheeseman; S. White; J. Margison 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Anthracyclines are amongst the most active drugs in the treatment of breast cancer. Stealth liposomal doxorubicin (Caelyx, Doxil, Alza Pharmaceuticals Inc.) is a promising new agent under investigation for the treatment of breast cancer and other solid tumours. The liposomal encapsulation alters dru